prick-test
发表于 2025-3-26 23:55:09
http://reply.papertrans.cn/32/3153/315214/315214_31.png
Incumbent
发表于 2025-3-27 03:47:49
http://reply.papertrans.cn/32/3153/315214/315214_32.png
确保
发表于 2025-3-27 07:56:02
Multimodal Therapy for Locally Advanced Esophageal Cancer,e two diseases entities should be treated differently. It is clear that chemotherapy or chemoradiotherapy should be given before surgery; however, perioperative systemic regimens have taken over the landscape for patients with EAC in many centers around the world. Although significant regional diffe
Interlocking
发表于 2025-3-27 12:01:13
Definitive Chemoradiotherapy for Esophageal Cancer,diotherapy (dCRT) is at least equivalent to trimodality therapy in terms of long-term survival for patients with esophageal squamous cell carcinoma (ESCC). Frail patients with ESCC who are not fit for surgery should receive dCRT. For those who are considered fit for esophagectomy, decision between d
BRIBE
发表于 2025-3-27 16:48:02
http://reply.papertrans.cn/32/3153/315214/315214_35.png
Obvious
发表于 2025-3-27 18:42:17
http://reply.papertrans.cn/32/3153/315214/315214_36.png
gorgeous
发表于 2025-3-28 01:19:40
Transhiatal Esophagectomy,proper patients for this procedure. For instance, this approach is not ideal for patients with severe mediastinal adhesions secondary to prior operations or radiotherapy or those with T4 tumors. Cancer of the distal esophagus and esophago-gastric junction are well suited for this procedure, as most
debris
发表于 2025-3-28 04:47:45
http://reply.papertrans.cn/32/3153/315214/315214_38.png
Lipoprotein(A)
发表于 2025-3-28 09:58:12
http://reply.papertrans.cn/32/3153/315214/315214_39.png
invulnerable
发表于 2025-3-28 12:54:26
http://reply.papertrans.cn/32/3153/315214/315214_40.png